MELISSA HOWIE: Open Payments
NPI 1285744268 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,967 in 161 payments from 28 companies in 2025. Trend: 2023 $2,972 · 2024 $3,424 · 2025 $3,967
Food & beverage: $3,967
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $724 |
| GENZYME CORPORATION | 18 | $479 |
| GlaxoSmithKline, LLC. | 18 | $411 |
| Regeneron Healthcare Solutions, Inc. | 21 | $313 |
| Amgen Inc. | 18 | $300 |
| PFIZER INC. | 13 | $296 |
| Novartis Pharmaceuticals Corporation | 13 | $264 |
| CSL Behring | 5 | $137 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $105 |
| Octapharma USA, Inc. | 1 | $96 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, BREZTRI, FASENRA, CIBINQO, Xolair, AYVAKIT.
Industry payments across CA — which companies pay providers there.
